SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001764013-23-000074
Filing Date
2023-06-26
Accepted
2023-06-26 07:35:54
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa14aadditionalmaterials.htm DEFA14A 11762
2 GRAPHIC immunovantinc_naxp96108xp9.jpg GRAPHIC 489486
3 GRAPHIC immunovantinc_naxp96108xp9a.jpg GRAPHIC 385030
  Complete submission text file 0001764013-23-000074.txt   1216929
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Filer) CIK: 0001764013 (see all company filings)

IRS No.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: DEFA14A | Act: 34 | File No.: 001-38906 | Film No.: 231039443
SIC: 2836 Biological Products, (No Diagnostic Substances)